申请人:Dana-Farber Cancer Institute, Inc.
公开号:US20170298056A1
公开(公告)日:2017-10-19
Described herein are small-molecule compounds that specifically inhibit a wide range of HIV-1 isolates without interfering with CD4 or CCR5 binding. Methods of using die compounds for treating or preventing HIV infection are also described.